ALLOVIR INC's ticker is ALVR and the CUSIP is 019818103. A total of 89 filers reported holding ALLOVIR INC in Q3 2022. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $718 | -31.2% | 333,722 | +8.7% | 0.00% | -50.0% |
| Q2 2023 | $1,044 | -40.8% | 307,105 | -31.4% | 0.00% | 0.0% |
| Q1 2023 | $1,764 | -16.9% | 447,800 | +8.2% | 0.00% | -33.3% |
| Q4 2022 | $2,123 | -99.9% | 413,800 | +42.4% | 0.00% | 0.0% |
| Q3 2022 | $2,293,000 | +94.8% | 290,600 | -3.7% | 0.00% | +200.0% |
| Q2 2022 | $1,177,000 | +228.8% | 301,701 | +468.2% | 0.00% | – |
| Q1 2022 | $358,000 | -35.3% | 53,100 | +89.6% | 0.00% | -100.0% |
| Q2 2021 | $553,000 | – | 28,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 5,577,167 | $44,004,000 | 1.88% |
| GMT CAPITAL CORP | 2,758,846 | $21,767,000 | 1.35% |
| Regency Capital Management Inc.\DE | 75,010 | $592,000 | 0.73% |
| Redmile Group, LLC | 1,907,969 | $15,054,000 | 0.58% |
| Samsara BioCapital, LLC | 82,336 | $650,000 | 0.15% |
| Alkeon Capital Management | 4,923,104 | $38,843,000 | 0.13% |
| Woodline Partners LP | 1,087,093 | $8,577,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 77,625 | $612,000 | 0.08% |
| CORNERCAP INVESTMENT COUNSEL INC | 44,987 | $355,000 | 0.07% |
| AMERICAN INTERNATIONAL GROUP, INC. | 1,143,634 | $9,023,000 | 0.07% |